Crizotinib

Crizotinib (brand name: Xalkori) is a medication used to treat certain types of cancer, primarily non-small cell lung cancer (NSCLC). It is specifically prescribed for patients whose cancer cells have a genetic mutation in the ALK (Anaplastic Lymphoma Kinase) gene.